The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Realisation of Investment

23 Dec 2014 07:00

RNS Number : 5280A
Braveheart Investment Group plc
23 December 2014
 



 

Braveheart Investment Group plc

Realisation of Investment

 

Braveheart Investment Group plc (AIM: BRH), the financial services company that facilitates SME growth through investment by public and private sector sources, today announces that it has realised its investment in one of its portfolio companies, Cascade Technologies Holdings Ltd ('Cascade'), as a result of the acquisition of that company by Emerson, a listed US engineering company, for an undisclosed cash consideration.

 

Braveheart acquired its minority shareholding in Cascade, a Stirling based manufacturer of gas analysers and monitoring systems using quantum cascade laser (QCL) technology, in 2006 and in 2008, investing an aggregate of £149,969. Braveheart will receive a net cash consideration of £389,655 for its shareholding.

 

Around 40 of Braveheart's private clients also realised their shareholding in Cascade and most should benefit from the tax reliefs provided by the Enterprise Investment Scheme (EIS).

 

Geoffrey Thomson, Chief Executive of Braveheart, commented: "We noted in our interim results announced on 15 December, that good progress was being made on the exit potential of the portfolio and we are pleased to announce this value-enhancing transaction."

 

 

 

For further information please visit www.braveheartinvestmentgroup.co.uk or contact:

 

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive

gthomson@braveheartgroup.co.uk

Tel: +44 1738 587555

 

Sanlam Securities UK Limited (Nominated Advisor and Broker to Braveheart)

Lindsay Mair

Tel: +44 20 7628 2200

 

Media Enquiries:

Allerton Communications

Peter Curtain

peter.curtain@allertoncomms.co.uk

Tel: +44 20 3137 2500

 

Notes to Editors:

Braveheart Investment Group provides a range of products and services to investors seeking exposure to SME investments. Our clients include high-net-worth individuals looking to build tax-efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios, public-sector organisations, family offices and other institutions. Products available range from self-build portfolios to a full fund management service.

 

Funds managed by Braveheart and its subsidiaries/associate companies include: the Crowdcube Venture Fund, the Finance Yorkshire Equity Fund, the NI Growth Loan Fund, the Lachesis Fund, the Strathclyde Innovation Fund, the Viking Growth Fund and the Viking Loan Fund. Our operating companies are Strathtay Ventures, Viking Fund Managers and, partnering with NEL Fund Managers and Clarendon Fund Managers, WhiteRock Capital Partners LLP.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLLLLZLFLFBF
Date   Source Headline
6th Sep 20227:00 amRNSHolding(s) in Company
2nd Sep 202211:20 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSAcquisition of further interest in Aukett Swanke
31st Aug 20225:00 pmRNSTotal Voting Rights
4th Aug 20223:27 pmRNSHolding(s) in Company
3rd Aug 20225:05 pmRNSAcq of interest in Aukett Swanke plc - Replacement
3rd Aug 20224:10 pmRNSAcquisition of interest in Aukett Swanke Group plc
21st Jul 20227:03 amRNSOperational update on Paraytec
13th Jul 202211:41 amRNSResult of AGM
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
27th Jun 20228:40 amRNSDirector/PDMR Shareholding
16th Jun 20227:00 amRNSFinal Results
9th May 20223:57 pmRNSReplacement - Cancellation and grant of options
9th May 20221:08 pmRNSCancellation and grant of options
29th Apr 20225:00 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSPlacing to raise £215,113
31st Mar 202212:17 pmRNSResult of General Meeting
28th Mar 20229:42 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSNotice of GM and authority to issue shares
14th Mar 202211:23 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSBlock admission six monthly return
8th Mar 20229:41 amRNSDirector/PDMR Shareholding
25th Feb 202211:06 amRNSSecond Price Monitoring Extn
25th Feb 202211:00 amRNSPrice Monitoring Extension
25th Feb 20227:00 amRNSOperational update
31st Jan 20227:00 amRNSHolding(s) in Company
28th Jan 20221:55 pmRNSHolding(s) in Company
21st Jan 20222:46 pmRNSOperational update on Paraytec
17th Jan 20223:23 pmRNSFurther re. Director/PDMR holding
17th Jan 20229:24 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSNon Regulatory - PhaseFocus Update
8th Dec 20214:08 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSOperational update on Paraytec
26th Nov 20219:49 amRNSVideo from The University of Sheffield re Paraytec
15th Nov 20217:00 amRNSHalf-year Report
14th Oct 20211:46 pmRNSDirector/PDMR Shareholding
11th Oct 202111:02 amRNSHolding(s) in Company
11th Oct 20217:30 amRNSInvestment in Autins Group plc
30th Sep 20215:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSOperational update on various investments
28th Sep 202112:14 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSBlock admission six monthly return
31st Aug 20215:00 pmRNSTotal Voting Rights
13th Aug 202111:05 amRNSSecond Price Monitoring Extn
13th Aug 202111:00 amRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSPlacing to raise £2.5 million
6th Aug 202111:05 amRNSSecond Price Monitoring Extn
6th Aug 202111:00 amRNSPrice Monitoring Extension
4th Aug 20212:40 pmRNSFurther update re Paraytec AD Scanner project
26th Jul 20215:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.